Yaping Z. Dai
1205 Guangrui Road
Wuxi, 214000, China
Wuxi, 214000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Prevalence of anti-mitochondrial antibodies and clinical features in autoimmune hepatitis (AIH) patients.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 18, 2025
Engineered chimeric myeloperoxidase (MPO) antibodies as candidate reference materials for MPO-ANCA detection.
Journal: Journal of immunological methods
Published: July 27, 2025
The Genomics/Genetics of Primary Biliary Cholangitis: The Case for a Functional SNP rs10893900 in ETS1/FLI1 and Review of the Literature.
Journal: Clinical reviews in allergy & immunology
Published: June 18, 2025
Application of the six sigma model to evaluate the analytical performance of serum lipid analytes and design quality control strategies: A multi-centre study.
Journal: Annals of clinical biochemistry
Published: June 11, 2025
Development of a chimeric monoclonal antibody as a potential diagnostic reference in PR3-ANCA detection.
Journal: Journal of immunological methods
Published: February 27, 2025
Comparison of efficacy and safety of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate treatment in patients with high viral load of hepatitis B virus.
Journal: Medicine
Published: December 21, 2024
Development of a standardized monoclonal antibody to the inner lipoyl domain of PDC-E2 as a potential international AMA reference.
Journal: Journal of translational autoimmunity
Published: October 19, 2024
Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis.
Journal: Journal of translational autoimmunity
Published: February 23, 2024
Association of CCR6 functional polymorphisms with Primary Biliary Cholangitis.
Journal: Journal of translational autoimmunity
Published: January 30, 2024
Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine.
Journal: Frontiers in immunology
Published: August 15, 2023
Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study.
Journal: Human vaccines & immunotherapeutics
Published: August 02, 2023
Last Updated: 09/26/2026